Research and Clinical Trials Cystic Fibrosis Foundation
That’s why we are funding the REACH study, which is enrolling people with CF not taking modulators. Study participants will provide health information and specimens (like blood samples) for researchers to compare to new treatments in development, including genetic therapies. Genetic therapies have potential to treat the underlying cause of CF, no matter what mutations […]